Innovation Pharmaceuticals Inc (IPIX)

[olden_grumpini]

There was an interesting paper published in the journal viruses about brilacidin: Brilacidin Demonstrates Inhibition of SARS-CoV-2 in Cell Culture. The finding of nearly 100% viral reduction comes from section 3.5. “Brilacidin in Combination with Other Antiviral Treatments: Synergistic Activity against SARS-CoV-2 in Combination with Remdesivir in Calu-3 Cells”.

What some people miss is that GMU also provided data for remdesivir and brilacidin tested independently, not in combination. Same virus, same conditions, head-to-head. In those tests GMU demonstrated that remdesivir inhibited the virus by 99% by itself. Brilacidin demonstrated a lower inhibition. The testing done at GMU showed that remdesivir was more potent than brilacidin. This is inconvenient for investors in IPIX, including myself, but that is what GMU has shown us.

Some posters have been making the claim that remdesivir is “worthless” and a "fraud", yet the research done at GMU have shown it to be more potent than brilacidin. Was the research conducted at GMU corrupt? Is that why brilacidin will succeed where remdesivir failed?